Veradermics, Incorporated (MANE) — Net Asset Quality Index
Veradermics, Incorporated (MANE) has a Net Asset Quality Index of 98.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $398.58 Million minus total liabilities of $6.72 Million yields net assets of $391.87 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Veradermics, Incorporated (MANE) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Veradermics, Incorporated Net Asset Quality Index Over Time (2023–2025)
This chart shows how Veradermics, Incorporated's Net Asset Quality Index has evolved across 3 annual periods from 2023 to 2025. As of March 2026, the index stands at 98.3%, representing net assets of $391.87 Million against total assets of $398.58 Million USD. Also explore MANE asset base for the complete picture of this company's asset base.
Annual Net Asset Quality Index for Veradermics, Incorporated (2023–2025)
The table below presents the year-by-year Net Asset Quality Index for Veradermics, Incorporated from 2023 to 2025, covering 3 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Veradermics, Incorporated (MANE) market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -79.3% | $-121.01 Million | $152.62 Million | $273.63 Million | ▼ -171.3 pp |
| 2024 | 92.1% | $54.66 Million | $59.38 Million | $4.72 Million | ▲ +12.9 pp |
| 2023 | 79.2% | $14.62 Million | $18.46 Million | $3.84 Million | — |